Investec 'C'onnect: Gland Pharma CEO Mr Srinivas Sadu
Loading player...
Investec 'C'onnect: Gland Pharma CEO Mr Srinivas Sadu
Other recent episodes
US Tariffs & Implications on Global Economy with Philip Shaw, Economist
Insights on the Indian market.
Investec View on Tariffs & Stock Impact in India
Insights on the Indian market.
Rising Stress in MFI - A Perspective from Credit Rating Agency
As of March 2024, the Gross loan portfolio of Micro Finance industry has grown to Rs 4.42 lakh crore, up 26.8% over the previous year. Though active loans have grown 14% YoY, the Average ticket size has also increased by 12% YoY. While the industry witnessed best of asset quality…
How as a SRO MFIN is taking steps for MFI Industry to cope with the current asset quality problems - Jiji Mammen
Insights on the Indian market.
What is the reasons for recent stress in MFI and the way out. - Chaitanya India
As of March 2024, the Gross loan portfolio of Micro Finance industry has grown to Rs 4.42 lakh crore, up 26.8% over the previous year. Though active loans have grown 14% YoY, the Average ticket size has also increased by 12% YoY. While the industry witnessed best of asset quality…